v3.26.3
CONVERTIBLE NOTES (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 25, 2026
Sep. 30, 2026
Sep. 30, 2026
Sep. 30, 2025
Jul. 06, 2026
Dec. 31, 2025
Nov. 14, 2025
Short-Term Debt [Line Items]                
Net cash proceeds [1],[2]       $ 1,955,000 $ 0      
Financial instruments [3]     $ 7,133,000 7,133,000     $ 0  
Convertible Debt [Member]                
Short-Term Debt [Line Items]                
Principal amount           $ 5.6    
Original Secured Note [Member]                
Short-Term Debt [Line Items]                
Principal amount               $ 3,000,000
Additional Secured Notes [Member]                
Short-Term Debt [Line Items]                
Principal amount     $ 1,025,000.000 $ 1,025,000.000        
Interest rate     24.00% 24.00%        
Maturity date Aug. 12, 2026              
New Note [Member]                
Short-Term Debt [Line Items]                
Interest expense     $ 450,000 $ 1,742,000        
New Note [Member] | Oramed And Creative Value Capital [Member]                
Short-Term Debt [Line Items]                
Principal amount   $ 10,000,000            
Interest rate   8.00%            
Additional capacity   $ 10,000,000            
Net cash proceeds   $ 5,400,000            
Maturity date   Mar. 25, 2029            
New Note [Member] | Oramed And Creative Value Capital [Member] | Freestanding Warrants [Member]                
Short-Term Debt [Line Items]                
Number of warrants issued   1,851,851            
Exercise price   $ 5.4            
July Notes [Member]                
Short-Term Debt [Line Items]                
Principal amount           $ 5,600,000    
Number of ordinary shares issuable upon exercise of warrants           1,033,331    
Interest rate           8.00%    
Additional capacity           $ 5,600,000    
Exercise price           $ 5.4    
Interest expense     7,000 7,000        
Debt Host [Member]                
Short-Term Debt [Line Items]                
Financial instruments     4,882,000 4,882,000        
Debt Host [Member] | July Notes [Member]                
Short-Term Debt [Line Items]                
Financial instruments     $ 17,000 $ 17,000        
[1] Includes proceeds from issuance of New Notes, derivative liabilities and warrant liabilities to Oramed Pharmaceuticals Inc., a related party, of $4,397 for the six months ended June 30, 2026.
[2] See Note 9a.
[3] Includes $4,387 thousand attributable to Oramed Pharmaceuticals Inc., a related party as of September 30, 2026. See Note 9.